Chinese Journal of New Drugs - Digital Cluster of Scitech Periodicals

Home>Journals>Chinese Journal of New Drugs

Chinese Journal of New Drugs

CSCD

ISTIC

PKU

ISSN：1003-3734

CN：11-2850/R

Frequency：Semimonthly

Website：http://www.newdrug.cn

Email：bianjibu@newdrug.cn

Postcode：100098

Articles12737

Citations124451

Funded4496

Impact Factor：2.35

Official Website

Articles

2025 No.24

Total 18 articles

Analysis of the current status and trends in recombinant protein vaccine research and developmentXU Li, LI Huan, LIU Min, LI Xiao-jing, HE Wu

2577-2584

Application of platform technology and regulatory considerations for innovative monoclonal antibody productsQIU Xiao, WANG Wen-bo, YANG Fei, ZHANG Meng-meng, GONG Xu, WEI Wei

2585-2588

Advances in artificial intelligence-driven neoantigen prediction algorithmLI Qian, WANG Xue, JIN Xiang-wan-er, KOU Ya-zhen, HUANG Ying, HE Wu

2589-2597

Quality risk management and considerations on evaluation of stem cell-derived pancreatic islet cell medicinal productsLIU Dan, LU Jia-qi, YIN Hui-fang, WEI Wei

2598-2604

Pharmaceutical technical requirements and prospects for cell-based regenerative medicine therapeutic drugsHAN Dong-mei, DONG Jing, WEI Wei

2605-2609

Analysis of common issues in quality control and evaluation of mesenchymal cell therapeutic drugsWEI Wei, CHENG Su-yuan, HAN Dong-mei, HE Wu

2610-2615

Research progress and pharmaceutical considerations on therapeutic cancer vaccinesWANG Xue, LI Qian, YANG Fei, HE Wu

2616-2621

CMC evaluation considerations for tumor-infiltrating lymphocyte in clinical trial applicationCUI Jing, WANG Xue, WEI Wei

2622-2628

Post-approval CMC submissions and regulatory considerations for autologous CAR-T cell productsWANG Jing-yu, WANG Xue, LU Jia-qi, WEI Wei

2629-2634

Requirements for re-registration of biological products in ChinaYUAN Rong-rong

2635-2638